Skip to main content

Robin Deacle

Vice President, Corporate Communications
Phone number: 
919-549-8824
E-mail: 
robin_deacle@ncbiotech.org

In her position at the North Carolina Biotechnology Center, Robin interacts with:

  • statewide partners who promote biotechnology and economic development
  • the news media
  • the general public

Biography

Robin directs and integrates the Center’s communications efforts, including the website, publications, public presentations, media relations, graphic design and marketing communications.

Background

Robin joined the Biotechnology Center in April 1999 as a public affairs specialist in charge of web content and drove the evolution of the Center's web presence.

During her tenure, Robin has held positions of increasing responsibility. Her accomplishments include organizing the State Fair exhibit, implementing the company CRM system and expanding the Center's electronic communications footprint.

Before joining the Biotechnology Center, Robin was a reporter for The Daily Press in Newport News, Va., the High Point Enterprise and the Burlington Times-News.

Robin is a Penn State University alumna, with a dual-degree in journalism and general science. She holds a certification in project management from N.C. State University and is a Certified Internet Webmaster.

Blogs

It was a gray afternoon in March, 2008 at the North Carolina Biotechnology Center. A kindly looking gentleman stood in our Congressional Room, surrounded by a group of North Carolina’s brightest young scientists, winners of various science competitions across the state that year.

Author's note: This post is adapted from a "Med Talk" I gave today at the Durham Convention and Visitors Bureau's Annual Tribute Luncheon. 

At the Biotech Center, our vision is for North Carolina to continue to be a global leader in life science.

If you’re a scientist or an introvert, one of the hardest things to do is talk about yourself.

Talking about it consistently enough to create a personal brand?

Anathema! (Bonus: you introverted scientists actually know what that means!)

Still, nearly 100 mostly introverted people, all scientists, turned out for the presentation, “Creating Your Personal Brand,” at Monday’s Jobs Network meeting. They listened as NC State’s John Hutchings told them just how important a personal brand is, not just to finding a job, but to their whole career.

Two full days.

Two days filled with conversations. Reuniting with old friends. Making new ones. Listening to thought leaders, company pitches and predictions of the next scientific breakthroughs.

The annual CED Life Science Conference had all of that. And after two full days of networking, we all went back to our offices to catch up on the work that we had missed in those two full days.

Cancer.

We’ve found some treatments that have great results for some cancers. We have ideas about other treatments, some that may work broadly against many cancers. Those ideas were widely discussed at the 2016 CED Life Science Conference.

So it was with great anticipation that we awaited the presentation by Katherine Yang. She led off the closing lunch session with her talk “Developing Cellularly Active Inhibitors of CARM1 for a New Anti-Cancer Treatment.”

We all know it. The world needs twice as much food by 2050.

We all know it. But commodity prices are low. And that decreases available resources for innovation in food production, pointed out one attendee at Tuesday's Ag Biotech Workshop.

Not so, responded one of the panelists. It's actually psychology.

For when food production is slightly ahead of demand, we think that there is plenty of food. Nothing to worry about.

The NCBiotech website has a new roadmap. How did this happen? Where's my favorite page? Well, I'm glad you asked.

Everyone has an elevator pitch, right? It's essential these days for networking.

Well, how about a two-minute pitch? That can get you millions of dollars?

One of our loan portfolio companies gave such a pitch at the recent CED conference. And brought home top honors for their efforts.
 

Yesterday I got to announce the launch of the North Carolina Life Sciences Talent Community.

With Illinois and Texas battling for headlines on best place for biotech businesses, I stood up and said North Carolina has the best workforce.

A Monday panel on venture philanthropy was ticking along nicely, talking about funding models, relationships and licensing terms.

Then Jigar Raythatha, chief business officer at Jounce Therapeutics, turned to the other panelists, and asked a big question.

Have you ever considered betting big on one very promising treatment?

After all, it could get a cure to market faster, what disease-specific charities are all about.

Articles

Global Agribusiness Executive Sees Opportunity for North Carolina John Rabby

North Carolina’s life science jobs continue to grow at more than triple the national average, pushing the total number of people employed in the sector statewide above 70,000 for the first time.

More than 500 participants in the NC State University College of Agriculture and Life Science and NCBiotech Ag Biotech Initiative joint North Carolina Agriculture and Biotechnology Summit are dealing with the challenge of feeding 9 billion people by the year 2050. And more.

Patheon is adding 488 jobs to its Greenville facility by the end of 2019 as part of a planned $159 million expansion of the site.

Michael Kelly, chief financial officer of Piedmont Pharmaceuticals, has been named chair of the newly seated 24-member Advisory Committee for Biotechnology in the Piedmont Triad and Daniel Erb, PT, Ph.D., dean of the High Point University School of Health Sciences, will serve as vice chair.

NCBiotech named Douglas L. Edgeton, a experienced leader in healthcare and life sciences, as the new President and CEO. Edgeton is currently senior vice president for financial planning and development at NCBiotech, with two decades of prior experience at academic medical centers, Wake Forest University and the University of Alabama at Birmingham.

Biogen Idec’s Machelle Sanders, GlaxoSmithKline’s David Stewart and BTEC's Nathaniel Hentz discussed the importance of North Carolina's workforce talent preparation to the state's biomanufacturing leadership, on a panel at the BIO International Convention.

Life science jobs in North Carolina have increased 7 percent since 2007, to more than 66,000 by the end of 2012. And despite the overall economic struggle to claw back from the Great Recession, life science salaries in the state rose nearly 13 percent, to $82,000, says a new report from Battelle,

The United Nations projects that by 2050, we’ll have nine billion people in the world. Those additional 1.8 billion people will need to eat. Where will all that food come from?

It’s a question that North Carolina companies are researching in earnest. 

Novartis trades some vaccines to GSK. GSK sells cancer portfolio to Novartis. Novartis and GSK combine consumer health lines. And Novartis Animal Health goes to Eli Lilly.